The Russian Federal Medical‑Biological Agency is working on a coronavirus vaccine that develops cellular immunity, as the latter may hold for up to 13-17 years, whereas antibodies provide immunity to the virus for only months, Veronika Skvortsova, the head of the FMBA said during a meeting with President Vladimir Putin, APA reports citing Sputnik.
“We have arrived at the first recipe for this medication, which is currently a vaccine candidate. We are now preparing for clinical trials. We hope to start them in the second half of the year”, Skvortsova commented on the next-gen shot now in the making.
She specified that it would be around July, responding to the president's question.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
